A mbient particulate matter (PM) of different sizes and traffic-related air pollution pose major threats to global public health. 1 Fine PM air pollution (PM in diameter <2.5 μm [PM 2.5 ]) is one of the leading causes of cardiovascular morbidity and mortality worldwide. 2 In East Asia, PM 2.5 ranks as the fourth ranking cause of disability-adjusted life years lost. 2 Numerous biological mechanisms, including endothelial dysfunction, higher blood pressure (BP), and increased atherosclerotic burden, have been proposed to be responsible for air pollution-associated adverse cardiovascular events; however, the precise pathways remain incompletely described. 1 
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lipid-free apoA-I (apolipoprotein A-I). 8 Impaired HDL-CEC has been linked to decreased NO synthase, increased apoptosis of endothelial cells, as well as heightened production of reactive oxygen species. 9 Epidemiological studies have shown that reduced HDL-CEC is positively associated with an increased incidence of cardiovascular events, including cardiovascular mortality and coronary artery atherosclerosis. 10, 11 The anti-inflammation and antioxidative capacities of HDL (eg, preventing the formation of oxidized lipoproteins) are additional actions that protect against cardiovascular events.
12 Although HDL plays a beneficial role in normal physiological conditions, mounting evidence supports that proinflammatory and oxidative stimuli can rapidly convert healthy to dysfunctional HDL. 7 Indeed, in patients with coronary diseases, concentrations of apoA-I chlorinated and oxidized by inflammatory mediators have been shown to be elevated and inversely related to HDL-CEC. 13 Moreover, in vitro studies have been demonstrated that the ability of apoA-I to remove excess cellular cholesterol from macrophages through the ABCA1 (ATP-binding cassette transporter A1) pathway is significantly impaired when apoA-I becomes modified by lipoxidation end products. 14 It is thus plausible that air pollution-a known instigator of inflammation and oxidative stress 15 -may be an important environmental factor in the genesis of dysfunctional HDL.
Few studies have evaluated the impact of air pollution on HDL functionality. Mixed results have been reported in response to a brief 2-hour controlled exposure to concentrated PM. 16 , 17 Recently, we demonstrated that acute exposures to low levels of ambient PM 2.5 were associated with significant impairments in HDL function (measured as HDL-CEC). 6 However, previous studies have focused on the impact of a single air pollutant (eg, PM 2.5 ) and were conducted in locations with relatively good air quality or in controlled experimental settings. Ambient air pollution in most urban areas is dominated by ultrafine particulates (UFPs; PM in diameter <0.1 μm), whereas traffic-related air pollution accounts for ≈60% of daily UFP exposures. 15 As such, it is of real-world importance to evaluate whether several different size fractions of PM (including UFPs) and metrics of traffic-related air pollution exposure (black carbon [BC] , nitrogen dioxide [NO 2 ], and carbon monoxide [CO] ) are capable of impairing HDL functionality in a heavily polluted urban setting. Moreover, the underlying mechanisms whereby air pollution can induce HDL dysfunction remain poorly understood and merit investigation.
In this prospective follow-up Beijing AIRCHD study (Air Pollution and Cardiovascular Dysfunction in Healthy Adults), we hypothesized that acute exposures to higher levels of ambient air pollution would impair several aspects of HDL function. We secondarily aimed to elucidate the underlying pathways responsible, focusing on systemic inflammation and oxidative stress. The primary study outcomes were measures of HDL function, including HDL-CEC and antioxidant activity. Secondary study outcomes included HDL cholesterol (HDL-C) and apolipoprotein levels, as well as metrics of systemic inflammation and oxidative stress.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on meritorious request.
Study Participants and Design
Seventy-three participants were recruited according to entry criteria into the Beijing AIRCHD study. 18 Participant inclusion criteria included self-reported nonsmoking healthy adults living in nonsmoking households aged 18 to 50 years without any preexisting cardiovascular diseases or risk factors (eg, hypertension, diabetes mellitus, or treated hyperlipidemia). Exclusion criteria included taking any medications (eg, cholesterol or BP-lowering medication, antioxidant), a fasting glucose >7.0 mmol/L, hypertension (resting BP >140/90 mm Hg), hypotension (resting BP <100/50 mm Hg), or pregnancy. A study sample size of 60 participants was calculated using a significance level (type I error) at 0.05 with 80% study power and a 10% dropout rate based on our previous results. 19 Approximately 93% of the participants lived in campus dormitories or within 1 kilometer from the on-campus fixed location air monitoring station. Cooking and smoking were not allowed in the dormitories, thus indoor sources of air pollution were largely eliminated.
All participants were scheduled to participate in 4 repeated clinic visits ranging from 3 to 4 months apart between November 2014 and January 2016 ( 
Clinical and Biomarker Measurements
During each clinical examination, participants were scheduled to arrive to the clinic between 8 and 10 am having fasted overnight.
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ABCA1
ATP-binding cassette transporter A1 Participants were interviewed at each visit using a standard protocol to collect demographic information (age, sex, body mass index, waist-to-hip ratio, smoking status, medical history, and residential address). After resting for 5 minutes, averages of 3 readings of heart rate and right upper arm BP were obtained in a sitting position using an autonomic sphygmomanometer (HEM-7200; Omron, Japan). Concentrations of high-sensitivity CRP (C-reactive protein; hs-CRP) and lipid profiles, including apoA-I, total cholesterol, HDL-C, LDL (low-density lipoprotein) cholesterol (LDL-C), and triglycerides, were measured by automatic analyzer (Beckman AU5800; Beckman Coulter) at the clinical laboratory of Peking University First Hospital. Plasma oxidized LDL levels were analyzed using a monoclonal antibody, mAb-4E6 (Mercodia AB, Uppsala, Sweden), with an interassay coefficient of variation of 5.5% at 8.5 mU/L. Spot morning urine samples were collected and stored at −20°C until later batched analysis. Urinary malondialdehyde (MDA) concentrations were measured using high-performance liquid chromatography equipped with a fluorescence detector at 532 nm (Waters, Milford, MA) with a coefficient of variation of 5.2% at 1 umol/L. The samples were also measured for urinary cotinine concentrations (IMMUNAL YSIS, Pomona, CA) and cortisol (LIUHEBIO, Wuhan, China) using a commercially available ELISA assay. All urinary measurements were normalized by urinary creatinine concentrations and expressed as mmol/mol creatinine for MDA and ng/mg creatinine for cotinine and cortisol.
HDL-CEC Measurement
HDL-CEC was measured by fluorescence-labeled cholesterol, 10, 20 which primarily evaluates ABCA1-specific CEC. Briefly, apoB was depleted in the plasma by polyethylene glycol (Sigma, S9318, St. Louis, MO). 21 RAW 264.7 macrophages (please see the Major Resource Table in the online-only Data Supplement) were maintained in DMEM (GIBCO, CA) plus 10% fetal bovine serum (GIBCO). Next, cells were plated on 96-well plates at a density of 10 4 cells/well and grown overnight. Cells were labeled with 5 μmol/L BODIPY (boron dipyrromethene difluoride linked to sterol carbon-24) cholesterol (Avanti; 810255P) for 1 hour, followed by a washing with DMEM. Cells were then incubated with 2 μg/mL of an ACAT (acyl-CoA cholesterol acyltransferase) inhibitor (Sigma, S9318, MO), 0.3 mmol/L 8-(4-chlorophenylthio)-cyclic AMP (Sigma, B5386, MO) and DMEM containing 2.8% apoB-depleted plasma for 4 hours. The resulting quantity of BODIPY cholesterol in the media or cells was individually determined with Multiscan Spectrum (excitation, 482 nm; emission, 515 nm). The CEC results were expressed as percentage cholesterol efflux.
HDL Antioxidation Capacity
HDL oxidation index (HDL-OI) was measured by the relative rates of dichlorofluoresce in fluorescence that are proportional to the levels of lipid hydroperoxides in HDL. 22, 23 This cell-free assay used CuCl 2 (Sigma, C3279, MO) as the lipid hydroperoxides-inducing agent. 24 Ten milliliters of dextran sulfate (10 mg/mL; Sigma, D8906, St. Louis, MO) solution was incubated with 100 μL of test plasma at room temperature for 5 minutes and then centrifuged at 8000g for 10 minutes. The supernatant containing HDL-C was used in the experiments after cholesterol determination. DCFH-DA (dichlorofluorescein diacetate; Life Technologies, C1165, CA) was dissolved in fresh methanol at 0.5 mg/mL and incubated at room temperature with protection from light for 30 minutes, resulting in the release of DCFH. Then, 100 μL HDL-C (10 μg/mL) was incubated with 10 μL CuCl 2 (60 μmol/mL) at 37°C for 1 hour using a black polystyrene 96-well plate. After incubation, 4 μL of DCFH solution was added to the HDL-Cu 2+ mixture in each well. Rates of fluorescence (excitation, 485 nm; emission, 530 nm) were determined by Multiscan Spectrum during the next hour at 15-minute intervals. Concentrations of HDL-OI measurements were expressed in arbitrary units (fluorescence per 1 μg of HDL-C per minute, RFU/µg HDL-C·min).
Air Pollution and Meteorologic Parameters
A fixed air pollution monitoring station has been set up on Peking University Health Science Center campus since 2014, which is located ≈100 and 600 meters away from 2 major busy roadways. 18 Hourly average concentrations of ambient PM 2.5 were measured using a beta attenuation monitor (BAM-1020; Met One Instruments, Inc). Five-minute particulate number concentrations (PNC) in the size ranges from 5 to 560 nm were measured by a TSI Fast Mobility Size Spectrometer (FMPS Model 3091, TSI). PNC in size of <50 nm (PNC ), 50 to 100 nm (PNC 50-100 ), and 100 to 560 nm (PNC 100-560 ) were calculated. Minute-to-minute BC concentrations were collected using a dual-wavelength aethalometer (AE-33; Magee Scientific). Minute-to-minute concentrations of sulfur dioxide (SO 2 ), NO 2 , and CO were determined by EC9800 series gas analyzers (EcoTech Pty. Ltd., Australia). Ambient temperature (°C) and relative humidity (%) were measured using a Met One unit (Met One Instruments, Inc) at the same station. To validate the reliability of pollutant concentrations measured at the fixed monitoring station, PM 2.5 and BC were measured for 24 hours before each clinical visit for each participant, using an active-flow personal monitor DataRAM (pDR-1500; Thermo Scientific) and a micro-Aethalometer instrument (AethLabs MicroAeth AE51), respectively. Daily averages were calculated from 9 am to 9 am for all environmental measurements.
Statistical Analyses
Summary statistics were calculated for outcomes and environmental measurements, including means (SD) and medians (range) for continuous variables and proportions for categorical variables. Spearman correlations were performed across measurements of air pollutants and meteorologic parameters. Concentrations of hs-CRP and MDA were log-transformed because of right-skewed distributions. HDL-OI measurement data were dichotomized at median value (3.49×10 5 RFU/µg HDL-C·min) for further analyses. 23 Generalized estimating equation models, which can account for clustering within individuals introduced by the repeated-measurement design, were used to estimate associations between biological outcomes and ambient air pollutants. A first-order autoregressive covariance structure was selected based on the smaller quasi-likelihood under the independence model criterion. Certain demographic covariates may affect the health outcomes, thus separate analyses were performed on associations between each outcome, demographic covariates, and air pollution exposures. First, basic models were built without including air pollutants. Backward stepwise regression was used to select the key outcome-related personal characteristics for each outcome according to literature and biological plausibility, 7, 25 including age, sex, body mass index, waist-to-hip ratio, day of the week of clinical visit, month of the blood withdrawal, and levels of LDL-C, triglycerides, and creatinine-adjusted urine cotinine. Daily temperature and relative humidity were further included and modeled with linear, squared, and cubic terms controlling for meteorologic effects. Seasonal variations in physical responses were also accounted by including sine and cosine terms of calendar dates of blood withdrawal for all generalized estimating equation models based on lower quasi-likelihood under the independence model criterion. The selected covariates in final models are summarized in Table I in the online-only Data Supplement. Second, single-pollutant generalized estimating equation models were developed by including pollutant variables to evaluate the impacts of air pollutants on study outcomes. A Gaussian variance structure was assumed for all continuous outcome variables, and a quasi-binomial variance was applied for categorical variable HDL-OI. For each pollutant, we focused on a range of short-term exposure periods, including averaged pollutant concentrations during the last 24 hours before each participant's clinic visit (moving average [MA] day 1 [1 MA day]), 1 to 2 days (2 MA days), 1 to 3 days (3 MA days) and so on, ≤7 MA days because most previous studies indicated that onsets of air pollution-associated cardiovascular events were likely within 7 days of exposure. 26, 27 Further, plots of pollutant concentrations and the predictive values of biomarkers derived from generalized estimating equation models were conducted to graphically illustrate relationships between air pollution and study outcomes.
In exploratory analyses, we examined the impacts of mediumterm exposures (14, 30, 45, and 60 MA days) to assess whether repeated air pollution exposures over longer period of time play a more prominent role on the health responses. Furthermore, stratified analyses were conducted based on participant's characteristics (sex, overweight status [body mass index, ≥25 kg/m 2 ]) and the median levels of systemic inflammation (hs-CRP) and oxidative stress (MDA). Interactions between strata were examined with Z test at the level of P <0.05. Lastly, sensitivity analyses were performed by (1) restricting participants with urinary cotinine levels <200 ng/mg creatinine to evaluate whether the associations could be partially affected by potential cigarette smoking 28 ; (2) restricting participants living within 1 km from our fixed monitoring station to determine potential exposure misclassification; (3) further adjusting urinary cortisol-a biomarker of the stress level; (4) considering the change-in-estimate criterion as an additional method for confounder identifications to assess the robustness of backward stepwise regression using in main models.
All estimates are presented as absolute or percent changes or odds ratios for above-median levels with 95% CIs associated with interquartile range (IQR) increases in air pollutant concentrations. Statistical significance was determined at the level of P <0.05. To control for type I error rate at a 0.05 level, a Bonferroni correction at a 0.006 (0.05/8) significance level was applied with comparisons between the biomarkers. All analyses were conducted in SAS statistical software (version 9.2; SAS Institute, Cary, NC).
Results
The characteristics of the study participants and biological outcomes are presented in the Significant decreases in HDL-C levels were observed in association with air pollutants (Figure 2A) . The largest decreases in HDL-C levels, ranging from 1.9 mg/dL (95% CI, −3.1 to −0.6) to 2.8 (95% CI, −4.7 to −0.9), were associated with IQR increases in PNC 50-100 , BC, NO 2 , and SO 2 at prior 5 to 7 MA days. As shown in Figure 2B , reductions in apoA-I levels were also significantly associated with IQR increases in exposures to all pollutants, with the largest reductions ranging from 9.6 (95% CI, −16.6 to −2.6) to 19.8 mg/dL (95% CI, −32.5 to −7.1) at prior 5 to 7 MA days. Concomitantly, significant reductions in HDL-C/apoA-I ratio were observed in associations with increases in PNC , BC, and SO 2 at prior 1 to 7 MA days ( Figure 2C ).
HDL-CEC was significantly reduced by 2.3% (95% CI, −4.3 to −0.3) to 5.0% (95% CI, −7.6 to −2.4) in association with IQR increases in PM 2.5 , PNC 100-560 , BC, NO 2 , and CO at prior 1 to 7 MA days ( Figure 3A) . We observed significant increases in HDL-OI with estimated odds ratios of 2.75, 2.90, and 2.20 associated with IQR increases in concentrations of PNC , PNC 50-100 , and SO 2 , respectively at prior 5 MA days ( Figure 3B ). Significant increases in oxidized LDL levels of 2.0 (95% CI, 0.2-3.9) to 6.4 U/L (95% CI, 1.1-11.6) were also observed in association with IQR increases in PNC 5-100 at prior 1 to 7 MA days ( Figure 3C ).
Elevated levels of hs-CRP were observed in association with exposures to multiple air pollutants-the most significant being an increase of 185.1% (95% CI, 90.6-279.6) per IQR increase in concentrations of SO 2 at prior 7 MA days ( Figure 4A ). Significant increases in MDA levels were also observed in associations with exposures to most pollutants, with the largest increases of 19.9% (95% CI, 0.8-42.7) to 115.8% (95% CI, 58. .2) associated with PNC 5-560 , CO, and SO 2 at prior 3 to 7 MA days ( Figure 4B ).
As shown in Figure I in the online-only Data Supplement, plots of the relationships between HDL measures and air pollutants showed that adjusted values of HDL-CEC, HDL-OI, and HDL-C were significantly associated with increases in PNC 50-100 , respectively. In exploratory analyses, medium-term exposures to air pollutants were also observed in associations with selected biomarkers (Tables IV and V in the online-only Data Supplement). Furthermore, the air pollution-associated reductions in HDL-CEC and apoA-I levels were greater among women and participants who had higher MDA levels (with P for interaction <0.05), whereas no significant interaction was observed in overweight status and hs-CRP levelstratified analyses (Tables VI through IX in the online-only Data Supplement). As shown in the sensitivity analyses, the overall observed associations remained robust after excluding participants with urinary cotinine levels >200 ng/mg creatinine and participants living beyond 1 km from fixed monitoring station (Table X in 
Discussion
We have shown here for the first time that short-and mediumterm exposures to higher levels of a variety of ambient air pollutants are associated with significant impairments in HDL functionality (eg, HDL-CEC and HDL-OI). Additional detrimental responses included reductions in circulating HDL-C and apoA-I levels, as well as elevations in atherogenic lipids (oxidized LDL) and metrics of systemic inflammation and oxidative stress (hs-CRP and MDA). Multiple pollutants, including different size-fractioned PM, traffic-related air pollution metrics (BC, NO 2 , and CO), and SO 2 (a marker of regional pollution from coal-fired power plants), were each associated with adverse responses (depending on the health outcome and MA day evaluated). Given the key role of HDL in preventing the development of atherosclerosis, our findings provide novel insights into important mechanisms whereby several different air pollutants can promote ischemic cardiovascular disease. Epidemiological evidence supports that impaired HDL-CEC increases in the risk of atherosclerosis and cardiovascular events. 10, 11 Each 1% decrease in HDL-CEC is associated with a 0.4% increase in the risk for atherosclerotic coronary artery disease. 11 In the Beijing AIRCHD study, we observed significant reductions in HDL-CEC of 2.3% to 5.0% associated with ambient air pollution exposure. The magnitude of adverse biological changes was relatively modest and thus the impact on the health of any single individual may be small. However, hundreds of millions of people are continually impacted by high levels of air pollution across numerous regions worldwide (Asia, Mideast, and Africa). As such, even small adverse health responses (such as observed herein) can translate into a serious threat to global public health given the enormous number of individuals adversely affected.
Few studies have previously evaluated the impact of air pollution on HDL functionality. To date, the findings have been mixed. 6, 16, 17 These differences might be because of variations in PM sizes or sources or differences in metrics of HDL functionality assessed. A study by Yin et al 5 reported that 2-week exposures to diesel exhaust particles did not induce changes in HDL-CEC in apoE-null mice. Similarly, we observed null associations between 2-hour controlled exposure to rural coarse PM and HDL-CEC in healthy adults. We speculated that larger coarse PM from rural sources might be less toxic in this regard or the brief time frame of exposure was insufficient to elicit HDL dysfunction. 16 Studies in vivo showed that systemic lipid peroxidation provoked by PM 2.5 and UFPs exposures could convert normal HDL into a dysfunctional form with impaired anti-inflammatory capacity. [3] [4] [5] A recent in vitro study reported that normal HDL could inhibit the harmful effects of diesel exhaust particles on endothelial cells and macrophages, whereas dysfunction HDL further promoted, rather than inhibited, diesel exhaust particle-induced oxidation. 29 Indeed, systemic and vascular inflammation have been proposed to convert normal healthy HDL into dysfunctional forms with a gain of proinflammatory proteins and impaired antiatherogenic properties. 7 In addition to the genesis of dysfunctional HDL particles (reduced CEC and increased HDL-OI), we observed that several ambient air pollutants were also associated with significant reductions in HDL-C and apoA-I levels. ApoA-I constitutes ≈70% of the HDL protein cargo, and gene deletion or mutation of apoA-I results in extremely low levels of HDL-C in mice and in humans. 30 Prior studies have shown that PM air pollution can decrease circulating HDL-C levels. 25, 31, 32 Evidence from a larger population-based study showed an inverse association of 1-year average BC exposure with HDL-C levels but null association for both short-and long-term PM 2.5 exposures. 25 However, Yitshak et al 31 reported a strong association of 3-month average PM 2.5 exposures with decreases in HDL-C levels. Rice et al 32 reported that exposure to PM 2.5 during welding was associated with acute decrease in HDL-C levels at lagged 18 hours. The biological mechanisms whereby air pollution influence circulating HDL-C levels in human have not been specifically elucidated. HDL-mediated CEC impairment might impede HDL maturation, leading to reduction in HDL-C levels. 7 Interestingly, the impacts of individual air pollutants on HDL-C and different metrics of HDL function were not always consistent. For instance, we found significant alterations of HDL-C and HDL-OI associated with UFPs and SO 2 exposures, whereas no significant effects were observed for HDL-CEC. These discrepancies suggest that reductions in HDL-C levels attributable to air pollutants might not be exclusively mediated by ABCA1-specific CEC pathway. Indeed, previous studies showed that acute-phase responses of inflammation were capable of reducing HDL levels and impairing CEC by the transporters scavenger receptor B-I and ABCG1 (ATP-binding cassette transporter G1) but not by ABCA1 mediated CEC. 33 Furthermore, inhibition of LCAT (lecithin cholesterol acyltransferase) activity and overexpression of CETP (cholesteryl ester transfer protein) may also contribute to changes in HDL-C levels. 7, 8 It has been demonstrated that LCAT is primarily activated by apoA-I. 30 LCAT can convert lipid-poor pre-β-HDL to larger HDL particles, whereas CETP exerts redistribution cholesteryl ester to apoB-containing lipoproteins, resulting in decreasing HDL-C levels.
7,30 Although we did not have data on LCAT and CETP activities, previous studies have shown that exposure to cigarette smoking, which has similar toxic constituents with PM pollutants, can be significantly associated with decreased LCAT and increased CETP activities. 34 Hence, it can be speculated that air pollution-associated alterations in HDLmediated CEC and activities of key cholesterol transporters and enzymes may be partially responsible for changes in circulating HDL-C levels.
The precise mechanism whereby air pollution promotes HDL dysfunction cannot be directly evaluated in this type of human panel (observational) study. Nevertheless, important insights can still be gained. We explored plausible pathways by examining the genesis of systemic inflammation and oxidative stress after air pollution exposure and their subsequent associations with HDL functionality. The biological plausibility of our findings has been explored by previous work. 14, 35, 36 When lipid-free apoA-I is modified by MDA in vitro, its ability to remove excess cellular cholesterol from macrophages by the ABCA1 pathway can be significantly impaired.
14 CRP was found to inhibit cholesterol efflux through increased oxidative stress and downregulation of ABCA1 expression. 36 Depletion of pre-β-HDL particles by human chymase treatment of HDL 3 can also significantly impair ABCA1 pathway. 37 HDL-C/apoA-I ratio is a surrogate biomarker of HDL size and particle number (HDL-P) that reflects changes in smaller lipid-poor HDL particles and the efficacy of reverse cholesterol transport. 38 Studies in vitro found that pre-β-1 HDL and the smaller HDL 3 particles were tightly associated with increased CEC via the ABCA1 pathway, 39, 40 whereas HDL 2 particles with a high content of sphingomyelin were highly efficient in decreasing CEC. 41 Recently, Bell et al 25 examined the cross-sectional association between exposure to air pollution and HDL-P, and they reported significant decreases in smaller HDL-P in relation to PM 2.5 exposure. In this study, we observed that increases in exposure to air pollutants were significantly associated with decreases in HDL-C/apoA-I ratio. Consistent with published studies, our findings suggested that air pollution-associated impaired ABCA1-specific CEC could be mediated by increases in systemic inflammation and oxidative stress and sequential decreases in small HDL particles.
The Beijing AIRCHD study has several strengths. First, the repeated-measurement study design allowed each participant to serve as their own control to better control for potential interactions between air pollution and other potential confounding factors across individuals. Second, although nonsmoking healthy adults were recruited, urinary cotinine concentrations were measured as a proxy of environmental tobacco smoke exposure to control the potential impact of passive smoking in the analyses. Third, greater variations in pollutant concentrations across clinical visits allowed us to assess the effects among a relatively small number of study participants with sufficient study power. Our study was also conducted in a globally important megacity representative of many contemporary urban locations across the developing world where hundreds of millions of people are impacted by the poor air quality. Conversely, a few study limitations merit discussion. The results may have been influenced by a selection bias given that most participants enrolled into the study were young, healthy adults. However, this design yields a methodologic approach with the least number of potentially confounding health parameters that might influence the variability of HDL function across a year. Our healthy study participants were also likely to be less susceptible to air pollution; nonetheless, adverse responses were still observed. It is plausible that more robust changes could occur in more susceptible populations (eg, patients with established cardiovascular disease, the elderly, or those with the metabolic syndrome). Further studies in this regard are warranted. In addition, although our study demonstrated significant associations, these results alone cannot prove causality given the observational trial design. Taken in conjunction with prior animal experiments, however, we think our findings add strong support to the contention that air pollutants are indeed capable of impairing HDL function. We acknowledge that follow-up trials are required to further elucidate the mechanistic pathways involved, as well as to help clarify the clinical and public health importance of these adverse responses.
In summary, we found that short-and medium-term exposures to high levels of ambient air pollutants were significantly associated with impairments in several aspects of HDL function, along with proatherogenic alterations in lipoprotein levels and oxidative status, as well as increased levels in systemic inflammation and oxidative stress. These findings support the potential proatherosclerotic nature of air pollution and provide novel insights into the underlying biological mechanisms potentially involved. They also highlight the relevance of continued efforts to reduce air pollution emissions and to validate clinical approaches to reducing exposures at a personal level (eg, air filtration, N95 respirators), particularly among at-risk patients residing in heavily polluted environments. 1 MA day, averaged pollutant concentrations during the last 24 h before each participant's clinic visit; 2 MA days, 1 to 2 d; 3 MA days, 1 to 3 d and so on ≤7 MA days. BC indicates black carbon; CO, carbon monoxide; hs-CRP, high-sensitivity C-reactive protein; MDA, malondialdehyde; NO 2 , nitrogen dioxide; PM 2.5 , particulate matter in diameter <2.5 μm; PNC x , particulate number concentrations in given size ranges (nm); and SO 2 , sulfur dioxide.
